58 related articles for article (PubMed ID: 25198660)
21. Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro.
Yin T; Shi P; Gou S; Shen Q; Wang C
PLoS One; 2014; 9(12):e114581. PubMed ID: 25521461
[TBL] [Abstract][Full Text] [Related]
22. IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.
Rodolfo M; Zilocchi C; Accornero P; Cappetti B; Arioli I; Colombo MP
J Immunol; 1999 Aug; 163(4):1923-8. PubMed ID: 10438927
[TBL] [Abstract][Full Text] [Related]
23. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
24. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
25. Increased IFNγ
Li X; Zhang Y; Chen M; Mei Q; Liu Y; Feng K; Jia H; Dong L; Shi L; Liu L; Nie J; Han W
Clin Cancer Res; 2017 Oct; 23(20):6031-6043. PubMed ID: 28706011
[No Abstract] [Full Text] [Related]
26. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
27. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
Aarts WM; Schlom J; Hodge JW
Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
[TBL] [Abstract][Full Text] [Related]
28. Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth.
Martin BK; Frelinger JG; Ting JP
J Immunol; 1999 Jun; 162(11):6663-70. PubMed ID: 10352284
[TBL] [Abstract][Full Text] [Related]
29. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
30. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
[TBL] [Abstract][Full Text] [Related]
31. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
32. Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
Shi X; Zhang X; Li J; Guo F; Hu Z; Jing Y; Bai L; Chen S; Wan P; Wang F; Gao J; Tan W
Urol Oncol; 2013 Aug; 31(6):883-93. PubMed ID: 21924648
[TBL] [Abstract][Full Text] [Related]
33. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells.
Dai S; Wan T; Wang B; Zhou X; Xiu F; Chen T; Wu Y; Cao X
Clin Cancer Res; 2005 Oct; 11(20):7554-63. PubMed ID: 16243831
[TBL] [Abstract][Full Text] [Related]
34. Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine.
Zhou F; Yang J; Zhang Y; Liu M; Lang ML; Li M; Chen WR
Clin Cancer Res; 2018 Nov; 24(21):5335-5346. PubMed ID: 30068705
[No Abstract] [Full Text] [Related]
35. Antitumor activity of mHSP65-TTL enhanced by administration of low dose cyclophosphamide in pancreatic cancer-bearing mice.
Xuan W; Yan Y; Wan M; Wu X; Ji D; Wang L; Lin C; Chen Y; Yu Y; Zhang X
Int Immunopharmacol; 2015 Jul; 27(1):95-103. PubMed ID: 25907246
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer.
Ouyang X; Liu Y; Zhou Y; Guo J; Wei TT; Liu C; Lee B; Chen B; Zhang A; Casey KM; Wang L; Kooreman NG; Habtezion A; Engleman EG; Wu JC
Stem Cell Reports; 2021 Jun; 16(6):1468-1477. PubMed ID: 33961792
[TBL] [Abstract][Full Text] [Related]
37. Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.
Meng Y; Efimova EV; Hamzeh KW; Darga TE; Mauceri HJ; Fu YX; Kron SJ; Weichselbaum RR
Mol Ther; 2012 May; 20(5):1046-55. PubMed ID: 22334019
[TBL] [Abstract][Full Text] [Related]
38. Induction of antigen-specific TH 9 immunity accompanied by mast cell activation blocks tumor cell engraftment.
Abdul-Wahid A; Cydzik M; Prodeus A; Alwash M; Stanojcic M; Thompson M; Huang EH; Shively JE; Gray-Owen SD; Gariépy J
Int J Cancer; 2016 Aug; 139(4):841-53. PubMed ID: 27037842
[TBL] [Abstract][Full Text] [Related]
39. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.
Laheru D; Biedrzycki B; Jaffee EM
Methods Mol Biol; 2013; 980():175-203. PubMed ID: 23359154
[TBL] [Abstract][Full Text] [Related]
40. Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?
Zheng L
Immunotherapy; 2014; 6(10):1017-20. PubMed ID: 25428641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
